- Approval Id
- 29f2f05fa154f9bb
- Drug Name
- TRUSOPT OPHTHALMIC SOLUTION 2%
- Product Name
- TRUSOPT OPHTHALMIC SOLUTION 2%
- Approval Number
- SIN08880P
- Approval Date
- 1996-08-28
- Registrant
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Licence Holder
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- SOLUTION
- Dosage
- **DOSAGE AND ADMINISTRATION**
When used as monotherapy, the dose is one drop of TRUSOPT Ophthalmic Solution in the affected eye(s) three times daily.
When used as adjunctive therapy with an ophthalmic beta-blocker, the dose is one drop of TRUSOPT in the affected eye(s) two times daily.
When substituting TRUSOPT for another ophthalmic antiglaucoma agent, discontinue the other agent after proper dosing on one day, and start TRUSOPT on the next day.
If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart.
- Route Of Administration
- OPHTHALMIC
- Indication Info
- **INDICATIONS**
TRUSOPT Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with:
- ocular hypertension
- open-angle glaucoma
- pseudoexfoliative glaucoma and other secondary open-angle glaucomas
- Contraindications
- **CONTRAINDICATIONS**
TRUSOPT is contraindicated in patients who are hypersensitive to any component of this product.
- Atc Code
- S01EC03
- Atc Item Name
- dorzolamide
- Pharma Manufacturer Name
- SANTEN PHARMACEUTICAL ASIA PTE. LTD.
- Company Detail Path
- /organization/santen-pharmaceutical-asia-pte-ltd
